dr. robson discusses differences between biosimilars and biologics in oncology
Published 4 years ago • 80 plays • Length 0:49Download video MP4
Download video MP3
Similar videos
-
0:55
dr. robson discusses the driving force behind biosimilar use in oncology
-
1:48
dr. markman on the concept of biosimilars in oncology
-
0:41
similarity of biosimilars and biologics
-
1:42
dr. verma discusses challenges with biosimilars in oncology
-
2:47
biologics vs. biosimilars: what’s the difference?
-
3:33
biosimilars: manufacturing and inherent variation
-
3:00
biosimilars: complex copycat drugs
-
6:07
manufacturing of biologics
-
0:57
dr. somer on the expansion of biosimilars in oncology
-
0:55
dr. slamon discusses the future of biosimilars in oncology
-
4:41
biologics, unbranded biologics, and biosimilars - what is the difference?
-
38:15
biosimilars and biologics
-
1:20
how to differentiate between a biologic, generic, and biosimilar drug
-
1:45
dr. weise discusses challenges with biosimilar acceptance in oncology
-
0:54
dr. brufsky discusses reasons to use biosimilars in oncology
-
51:06
biosimilars and oncology clinical pathways: perfect together
-
0:45
dr. preeshagul on education for biosimilars in oncology
-
0:44
dr. hamilton on the impact of biosimilars in oncology
-
7:21
biologic drugs and biosimilars
-
0:57
what's the difference between a biologic and a biosimilar?
-
1:01
biosimilars video series: differences and similarities between biologics and biosimilars
-
1:37
dr. rugo discusses the regulatory process behind biosimilars